The influence of calcitriol and methylprednisolone on podocytes function in minimal change disease in vitro model.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
05 08 2023
Historique:
received: 13 04 2023
accepted: 01 08 2023
medline: 7 8 2023
pubmed: 6 8 2023
entrez: 5 8 2023
Statut: epublish

Résumé

Minimal change disease (MCD), considered one of the major causes of nephrotic syndrome, is a complex pathological condition with disturbances in podocytes' foot processes. Numerous studies suggested the essential role of vitamin D3 in maintaining proper glomerulus function. However, the data on direct potential of that compound in reference to podocytes are scarce. Thus, here we assessed the influence of calcitriol (active vitamin D3) on podocyte function, apart from commonly used steroids (methylprednisolone). CIHP-1 podocyte cell line was used to implement the LPS-PAN-induced MCD in vitro model. Viability, podocyte-related slit diaphragm proteins, morphology, function as a barrier was evaluated using flow cytometry, RT-PCR, confocal microscopy, and TEER analysis. Calcitriol or methylprednisolone did not affect cell viability. Podocyte-related proteins demonstrated different responses to in vitro treatment compared to previously reported changes in total glomeruli. Podocyte morphology was partially restored in the presence of the tested compounds. In addition, TEER analysis revealed improvement of LPS-PAN-induced cells' function as a barrier when vitamin D3 or steroid was used. In conclusion, a significant potential for modulation of MCD in vitro model podocytes with calcitriol or selected steroids was reported. Further studies on vitamin D3 in context of podocyte-related phenomenon accompanying MCD are of great importance.

Identifiants

pubmed: 37543700
doi: 10.1038/s41598-023-39893-x
pii: 10.1038/s41598-023-39893-x
pmc: PMC10404287
doi:

Substances chimiques

Calcitriol FXC9231JVH
Methylprednisolone X4W7ZR7023
Lipopolysaccharides 0
Cholecalciferol 1C6V77QF41

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12731

Informations de copyright

© 2023. Springer Nature Limited.

Références

J Am Soc Nephrol. 2002 Mar;13(3):630-638
pubmed: 11856766
J Am Soc Nephrol. 2009 Aug;20(8):1669-76
pubmed: 19578008
Metabolites. 2020 Mar 19;10(3):
pubmed: 32204545
Annu Rev Physiol. 2016;78:437-61
pubmed: 26863327
Clin J Am Soc Nephrol. 2017 Feb 7;12(2):332-345
pubmed: 27940460
Ter Arkh. 2013;85(6):10-6
pubmed: 23866593
Nephron. 2002 Apr;90(4):471-6
pubmed: 11961407
Int J Immunopathol Pharmacol. 2005 Oct-Dec;18(4):779-90
pubmed: 16388728
Am J Physiol Renal Physiol. 2012 May 1;302(9):F1084-9
pubmed: 22301621
Kidney Int Rep. 2017 Sep 28;3(1):168-177
pubmed: 29340328
Biomed Res Int. 2020 Jul 11;2020:4137268
pubmed: 32766307
Cell Physiol Biochem. 2021 Apr 17;55(S4):13-34
pubmed: 33861526
J Chin Med Assoc. 2018 Aug;81(8):691-698
pubmed: 29748075
J Cell Commun Signal. 2013 Mar;7(1):49-60
pubmed: 23161414
Ren Fail. 2012;34(3):403-7
pubmed: 22250862
Nephron Exp Nephrol. 2012;122(1-2):36-50
pubmed: 23548800
Kobe J Med Sci. 2020 Mar 27;65(5):E153-E163
pubmed: 32249272
Hum Pathol. 2011 Feb;42(2):227-35
pubmed: 21106221
J Am Soc Nephrol. 2006 Sep;17(9):2443-56
pubmed: 16885410
Biomark Res. 2014 Nov 23;2:21
pubmed: 25789166
Diabetologia. 2011 May;54(5):1227-41
pubmed: 21318407
Nephrol Dial Transplant. 2008 Oct;23(10):3138-45
pubmed: 18458033
J Am Soc Nephrol. 2012 Dec;23(12):1977-86
pubmed: 23123403
Nephrology (Carlton). 2012 Aug;17(6):525-31
pubmed: 22591222
Mol Cell Biochem. 2015 Jan;399(1-2):155-65
pubmed: 25292315
Clin Exp Nephrol. 2013 Dec;17(6):811-8
pubmed: 23377573
Calcif Tissue Int. 2021 Aug;109(2):157-178
pubmed: 33895867
Curr Med Chem. 2018;25(27):3256-3271
pubmed: 29446731
J Matern Fetal Neonatal Med. 2005 Jan;17(1):3-18
pubmed: 15804781
J Am Soc Nephrol. 2009 Oct;20(10):2181-9
pubmed: 19713307
Physiol Rev. 2003 Jan;83(1):253-307
pubmed: 12506131
Nephron Exp Nephrol. 2009;113(3):e89-96
pubmed: 19684413
Am J Hum Genet. 2011 Jul 15;89(1):139-47
pubmed: 21722858
J Toxicol Pathol. 2018 Jan;31(1):55-59
pubmed: 29479141
J Diabetes Investig. 2016 Sep;7(5):680-8
pubmed: 27180929
Kidney Int. 2021 Oct;100(4S):S1-S276
pubmed: 34556256
J Clin Invest. 2000 Nov;106(10):1281-90
pubmed: 11086029
J Cell Physiol. 2018 Sep;233(9):7173-7181
pubmed: 29574897
Kidney Blood Press Res. 2019;44(1):72-87
pubmed: 30808855
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
J Int Med Res. 2007 May-Jun;35(3):338-45
pubmed: 17593862
PLoS One. 2018 Jun 20;13(6):e0198013
pubmed: 29924795
Am J Physiol Renal Physiol. 2011 Sep;301(3):F660-71
pubmed: 21632959
PLoS One. 2012;7(5):e36041
pubmed: 22615747
Am J Physiol Renal Physiol. 2012 Mar 15;302(6):F647-57
pubmed: 22169009
Medicina (Kaunas). 2021 Feb 22;57(2):
pubmed: 33671780

Auteurs

Kamil Grubczak (K)

Department of Regenerative Medicine and Immune Regulation, Medical University of Białystok, Jerzego Waszyngtona 13, 15-269, Białystok, Poland. kamil.grubczak@umb.edu.pl.

Aleksandra Starosz (A)

Department of Regenerative Medicine and Immune Regulation, Medical University of Białystok, Jerzego Waszyngtona 13, 15-269, Białystok, Poland.

Barbara Makowska (B)

Department of Regenerative Medicine and Immune Regulation, Medical University of Białystok, Jerzego Waszyngtona 13, 15-269, Białystok, Poland.

Zuzanna Parfienowicz (Z)

Department of Regenerative Medicine and Immune Regulation, Medical University of Białystok, Jerzego Waszyngtona 13, 15-269, Białystok, Poland.

Magdalena Krętowska (M)

Department of Regenerative Medicine and Immune Regulation, Medical University of Białystok, Jerzego Waszyngtona 13, 15-269, Białystok, Poland.

Beata Naumnik (B)

Ist Department of Nephrology and Transplantation with Dialysis Unit, Medical University of Bialystok, Żurawia 14, 15-540, Białystok, Poland. bnaumnik@poczta.onet.pl.

Marcin Moniuszko (M)

Department of Regenerative Medicine and Immune Regulation, Medical University of Białystok, Jerzego Waszyngtona 13, 15-269, Białystok, Poland.
Department of Allergology and Internal Medicine, Medical University of Białystok, Marii Skłodowskiej-Curie 24A, 15-276, Białystok, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH